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Breast Cancer among Women Living in Poverty: 
Better Care in Canada than in the United States
Kevin M. Gorey, Nancy L. Richter, Isaac N. Luginaah, Caroline Hamm, Eric J. Holowaty, 
Guangyong Zou, and Madham K. Balagurusamy
This historical study estimated the protective effects of a universally accessible, single-payer 
health care system versus a multipayer system that leaves many uninsured or underinsured by 
comparing breast cancer care of women living in high-poverty neighborhoods in Ontario 
and California between 1996 and 2011. Women in Canada experienced better care, par-
ticularly as compared with women who were inadequately insured in the United States. 
Women in Canada were diagnosed earlier (rate ratio [RR] = 1.12) and enjoyed better access 
to breast conserving surgery (RR = 1.48), radiation (RR = 1.60), and hormone therapies 
(RR = 1.78). Women living in high-poverty Canadian neighborhoods even experienced 
shorter waits for surgery (RR = 0.58) and radiation therapy (RR = 0.44) than did such 
women in the United States. Consequently, women in Canada were much more likely to 
survive longer. Regression analyses indicated that health insurance could explain most of the 
better care and better outcomes in Canada. Over this study’s 15-year time frame 31,500 late 
diagnoses, 94,500 suboptimum treatment plans, and 103,500 early deaths were estimated in 
high-poverty U.S. neighborhoods due to relatively inadequate health insurance coverage. 
Implications for social work practice, including advocacy for future reforms of U.S. health 
care, are discussed.
KEY WORDS: breast cancer; health care reform; health insurance; Patient Protection and 
Affordable Care Act; poverty; single-payer system
The population of people who live in poverty in the United States rose markedly from 37.5 to 46.2 million between 2007 and 2011. 
During this period, which has come to be known as 
the Great Recession, the population of people in the 
United States who were uninsured also increased sig-
nificantly, to more than 50 million ( DeNavas-Walt, 
Proctor, & Smith, 2012). Including people who were 
underinsured, those with health insurance but with-
out the financial means of absorbing typically uncov-
ered costs of care, doubled the estimated inadequately 
insured population to 100 million ( Kaiser Family 
Foundation, 2012;  Schapmire, Head, & Faul, 2012). 
Along with presidential advocacy, this group probably 
represented a social force that could no longer be 
ignored and long-awaited reform of U.S. health care, 
the Patient Protection and Affordable Care Act (ACA) 
became law in 2010. Commonly called Obamacare, 
it is bound to make health care accessible for tens of 
millions more Americans ( Congressional Budget Of-
fice [CBO], 2012). However, the same report estimated 
that it could leave as many as 25 million people unin-
sured or underinsured.
Canada is of particular comparative social policy 
interest. Its poverty prevalence of approximately 
10% did not increase significantly during the Great 
Recession ( Murphy, Zhang, & Dionne, 2012), and 
its entire population is insured for medically neces-
sary care by a single, public payer. Universal health 
care is a strong element of Canada’s social safety net 
that, relative to the United States’, seems to have 
provided better protection during a time of eco-
nomic decline. The  National Association of So-
cial Workers (2009) and regional social work 
associations in coalition with others (for example, 
 Healthcare-Now, 2014) have long advocated for 
single-payer reform. Although most celebrated the 
passage of the ACA, their advocacy on behalf of 
uninsured and underinsured people continues. Ad-
vocates, adversaries, scholars, and policymakers won-
der the following: How much of an improvement is 
the ACA likely to make on key health care indica-
tors? And how much more improvement might be 
realized if single-payer reform were enacted in the 
United States? Definitive answers will necessitate 
prospective investigations. In the meantime  historical 
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investigations can advance useful knowledge. This 
study aims to advance such knowledge by examin-
ing evidence on one sentinel indicator among key 
informative populations during an instructive pe-
riod: breast cancer care among women who lived 
in high-poverty U.S. or Canadian neighborhoods 
during the years immediately prior to ACA’s 
 passage.
LITERATURE REVIEW
High-Poverty Neighborhoods in the 
United States and Canada
Four of every 100 U.S. residents live in high-poverty 
neighborhoods. These places, where 30% to 40% 
or more of the people have very low incomes, have 
been described as places of prevalent demographic 
vulnerability (  Jargowsky, 2005;  Wilson, 2012). In 
addition to people with inadequate incomes, such 
neighborhoods have high concentrations of people 
of color, people who are unemployed or who have 
withdrawn from the labor market, part-time service 
workers, recipients of social assistance, and people 
who are homeless. Such places seem particularly 
distressed for their lack of social and economic cap-
ital ( Kawachi, 1999). Adequate health insurance, 
itself a type of social and economic capital, has been 
observed to be profoundly lacking among people 
who live in high-poverty U.S. neighborhoods, 
 especially among those who may need it most, 
such as people with illnesses that require costly care. 
For example, people with cancer in high-poverty 
 California neighborhoods were recently observed to 
be nearly two times as likely to be uninsured, up to 
12 times as likely to be insured by Medicaid, but only 
half as likely to have private health insurance as were 
their counterparts in relatively low-poverty neigh-
borhoods. Of most policy interest was the fact that 
better treatment access and outcomes observed 
among residents of more affluent neighborhoods 
were largely explained by the intermediate effect of 
their having adequate health insurance, that is, pri-
vate or Medicare coverage ( Gorey et al., 2012, 2013).
There seems to be less descriptive information 
about high-poverty neighborhoods in Canada. This 
is perhaps not surprising as such neighborhoods 
are  less prevalent in Canada ( Broadway, 1989; 
 W. Chen, Myles, & Picot, 2012). Still, they do exist. 
In fact, two of every 100 Ontarians live in such 
high- poverty neighborhoods where 40% or more 
of the people spend two-thirds or more of their 
income on life’s necessities ( Gorey, 1998;  Statistics 
Canada, 2002). A seemingly small estimate—half 
that of the United States’—it represents a very siz-
able population of more than half a million Cana-
dians. Though the health risks, including cancer 
risks that Canadians are exposed to, are quite similar 
to those that their counterparts in the United States 
experience ( Gorey, Holowaty, Laukkanen, Fehringer, 
& Richter, 1998;  Krieger et al., 2002;  Lemstra, 
Neudorf, & Opondo, 2006;  Mustard, Derksen, 
 Berthelot, & Wolfson, 1999), Canadians living in 
high-poverty neighborhoods seem to have one dis-
tinct advantage. They enjoy access to Canada’s 
single-payer health care system. Consequently, such 
between-country comparisons on cancer care in 
high-poverty neighborhoods are likely to reveal the 
relative risks of being uninsured or underinsured in 
the United States.
Breast Cancer Care in High-Poverty U.S. 
and Canadian Neighborhoods
Breast cancer care seems a very useful sentinel indi-
cator of health care performance. The most common 
type of cancer among women in North America, 
directly affecting one of every eight to nine such 
women during their lives; its prognosis is typically 
excellent with early diagnosis and timely access to 
the best treatments ( Coleman et al., 2008). More-
over, for a number of reasons it may be particularly 
instructive for Canada–U.S. comparisons. First, in-
come has been observed to be strongly associated 
with breast cancer care and survival in the United 
States, but not in Canada ( Gillan et al., 2012;  Gorey, 
2009;  McKenzie & Jeffreys, 2009). Second, in the 
United States women with private health insurance 
or Medicare coverage are more likely to receive bet-
ter care than are women with arguably less adequate 
coverage, such as that provided through the Med-
icaid programs of many states, or none ( Coburn 
et al., 2008;  Gorey et al., 2013;  Schueler, Chu, & 
Smith-Bindman, 2008;  Subramanian et al., 2011). 
And third, studies of breast cancer survival in 
 Canada and the United States have consistently ob-
served better survival in Canada among the poor, 
but no systematic differences within middle or upper 
socioeconomic strata ( Gorey, 2009). In short, breast 
cancer care seems quite sensitive to the sorts of social 
and policy forces that probably determine much of 
the observed income and health insurance inequities 
in North America.
Because cancer registries in Canada and the 
United States do not typically include income data, 
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these studies were all ecological with respect to 
 income. They used census tracts to define low- 
income neighborhoods that typically only ranged 
from 10% to 20% poor. So they had limited power 
to study breast cancer care among the “truly disad-
vantaged” ( Wilson, 2012) people who live in Amer-
ica’s poorest neighborhoods. A preliminary study 
that described the experiences of such women with 
breast cancer in Canada and the United States be-
tween 1998 and 2006 found that the Canadian 
women experienced significantly better treatment 
access and outcomes. They were diagnosed earlier 
and were more likely to receive breast conserving 
surgery (BCS) as well as radiation and hormone 
therapies. Contrary to much political rhetoric, the 
Canadian women were less likely to experience 
long waits for surgery or radiation therapy ( Gorey, 
 Luginaah, Hamm, Fung, & Holowaty, 2010). More 
inclusive health insurance coverage in Canada was 
advanced as the most plausible explanation, but this 
theory was not directly tested as health insurance 
variables were not available. Moreover, this study only 
observed the experiences of 100 women, living in 
poor, but not extremely poor, neighborhoods. The 
present study aims to put this health insurance hy-
pothesis to a more recent, focused, and powerful test.
HYPOTHESES
We are unaware of any study that has compared 
breast cancer care between adequate samples of 
women living in extremely impoverished neighbor-
hoods in Canada and the United States who were 
also known to be adequately insured, inadequately 
insured, or uninsured. This one does so between 
1996 and 2011. We hypothesized the following: (a) 
Overall, Canadian women with breast cancer who 
live in such high-poverty neighborhoods will expe-
rience better cancer care and survival compared with 
their counterparts in the United States, (b) Canadian 
breast cancer care and survival will be better when 
compared with the care received by inadequately 
insured Americans (uninsured or Medicaid insured), 
and (c) relative protective effects among the Cana-
dian women will be explained by the intermediate 
effect of their all having health insurance.
METHOD
Sampling the Historical Cohorts
We chose to study California and Ontario to max-
imize both internal and external validity. They are 
the most populous state and province, respectively, 
and their comprehensive cancer registries contribute 
to their respective national cancer surveillance sys-
tems with demonstrated validity ( Gorey, Luginaah, 
Holowaty, Fung, & Hamm, 2009;  Hall, Schulze, 
Groome, Mackillop, & Holowaty, 2006;  Wright, 
1996). This study secondarily analyzed the high-
poverty strata of a California–Ontario breast cancer 
database that originally randomly selected women 
from high-, middle-, and low-poverty neighbor-
hoods. Women with malignant breast cancer were 
randomly selected from three geographic strata in 
Ontario and California between 1996 and 2000: 
very large metropolitan areas (Toronto versus San 
Diego, San Francisco, and Los Angeles), smaller 
metropolitan areas (Windsor versus Salinas, 
Modesto, Stockton, Bakersfield, and Fresno), and 
rural places. They have been followed, thus far, until 
January 1, 2011. We retrospectively collected data 
on breast cancer stage at diagnosis and treatments 
from health records across the province of Ontario 
to augment the Ontario Cancer Registry (OCR). 
Given the relatively high cost, we were able to sam-
ple 300 women from high-poverty neighborhoods 
in Ontario. We over sampled 1,950 women from 
high-poverty neighborhoods in California. Over-
sampling costs were negligible as all of this study’s 
variables were routinely coded by the California 
Cancer Registry (CCR). Bolstering statistical power 
to detect meaningful between-country differences, 
California participants served as multiple “controls” 
for the Ontario participant “cases” in a ratio of 6.5 to 
1. This study was powered to detect rate differences 
of 10%, with 80% power at a two-tailed significance 
level of 5% ( Fleiss, Levin, & Paik, 2003;  Hennessy, 
Bilker,  Berlin, & Strom, 1999). Subsample analyses 
that were necessarily less powerful could be deemed 
exploratory. Any such finding that met the more 
liberal significance criterion of 10% was reported as 
approaching significance ( p < .10).
High-Poverty Cohort Definitions
Conceptually similar definitions of economic de-
privation are used by Statistics Canada and the U.S. 
Census Bureau. Both are based on annual income 
adjusted for household size, but the Canadian low-
income cutoff is approximately 140% of the U.S. 
poverty threshold ( Osberg, 2000). Although not 
identical, our previous experience suggested that 
these two measures could be used to construct very 
similar “high-poverty” cohorts in California and 
Ontario. After first linking eligible women who 
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were diagnosed with breast cancer in California to 
the 2000 census by their residential census tract, we 
randomly selected our sample from tracts where 30% 
or more of the households met the federal poverty 
criterion (range = 30% to 100%, median = 36.8% 
poor;  U.S. Census Bureau, 2002). We then similarly 
selected from the poorest Ontario tracts (range = 15.0% 
to 52.8%, median = 22.7% low-income;  Statistics 
Canada, 2002). The resultant median annual house-
hold incomes in U.S. dollars ( Bank of Canada, 2014) 
were quite similar in California ($23,325) and On-
tario ($25,100). We used census tracts to represent 
extremely poor neighborhoods for this study of 
cancer care in Canada and the United States for the 
following reasons. First, validating studies in the 
United States found such tracts to be more predic-
tive of diverse personal health problems and social 
ills than either smaller, block group or larger, zip 
code–based measures ( Krieger, Chen, Waterman, 
Rehkopf, & Subramanian, 2003;  Krieger et al., 
2002). Second, such tracts typically have approxi-
mately 4,000 inhabitants who are similarly poor on 
both sides of the Canadian–U.S. border ( Gorey et al., 
2010,  2011). And third, such census tract–based 
poverty measures have been found to similarly pre-
dict the incidence of common types of cancer, in-
cluding breast cancer, in Canada and the United 
States ( Gorey et al., 1998).
Cancer Registry Variables
Variables coded by the CCR or by our research 
team to augment the OCR were as follows: stage 
of disease at diagnosis (node negative [NN], node 
positive [NP], or distally metastasized); receipt of 
initial surgery; type of surgery (BCS or mastec-
tomy); receipt of radiation therapy (RT), chemo-
therapy (CT), or hormone therapy (HT); wait times 
from diagnosis to treatment; and survival time from 
diagnosis to death or follow-up at 10 years. NN 
disease has not yet spread to any regional lymph 
nodes and is the most treatable type of breast cancer, 
whereas distally metastasized disease has spread be-
yond regional lymph nodes to other parts of the 
body. Surgery is indicated in most instances. BCS 
or lumpectomy is recommended for most NN breast 
cancers. Adjuvant treatments like RT, CT, and HT 
are typically received after surgery to further assist 
in the elimination or reduction of cancer cells 
( Brant, Ziegler, & Kairon, 2014;  McCready et al., 
2005;  Morrow et al., 2002). Various long-wait 
 criteria that may be associated with breast cancer 
recurrences, metastases, or shorter survival were ex-
plored ( Bilimoria et al., 2011;  Z. Chen, King, Pearcey, 
Kerba, & Mackillop, 2008).
These variables had less than 3% missing data. 
Agreements were very high among three health re-
cord abstractors who collected augmenting data for 
the OCR. An interrater reliability assessment of 50 
randomly sampled records found that kappa coef-
ficients ranged from 0.88 to 0.96 across study vari-
ables. For the California cohort, health insurance 
status, the primary source of payment to the hospi-
tal or primary payer, was determined from health 
records during the initial course of cancer treatment. 
It was categorized as follows: uninsured (11.6%), 
Medicaid (15.0%), Medicare (32.1%), or privately 
insured (41.3%). Given our oversampling of high-
poverty neighborhoods, the relatively low represen-
tation of people who were uninsured may seem 
surprising. Note, though, that most initial breast 
cancer care took place in hospitals where social 
workers worked to connect people who were un-
insured and poor to additional resources, typically 
Medicaid.
Statistical Analyses
In comparing survival, early diagnosis, or treatment 
rates between the two study cohorts, we first directly 
adjusted them for age and any other significant and 
substantial covariates using this study’s sample as the 
standard and reported as rates per 100 participants 
or percentages. Then we used standardized rate ra-
tios (RRs) for between-country comparisons with 
pooled 95% confidence intervals (CIs) derived from 
the chi-square test. Logistic regression models tested 
hypotheses about mediating effects of health insur-
ance on country–breast cancer survival relationships. 
We estimated odds ratios (ORs) and 95% CIs from 
logistic regressions and imputed missing data from 
full models. Binary survival outcomes (survived or 
not) that were best predicted by significant main 
effects and interactions were analyzed and reported 
( Agresti, 2002;  Hosmer & Lemeshow, 2000). In 
each instance, we ran logistic regression models that 
included four predictors: (1) country alone; (2) 
country and health insurance; (3) country, health 
insurance, and stage of disease at diagnosis; and (4) 
country, health insurance, stage, and treatments. 
These, respectively, assessed the significance of Ca-
nadian protective effects, their mediation or expla-
nation by health insurance, and the main and any 
additional mediating effects of early diagnosis and 
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timely surgical and adjuvant treatments. Other 
methodological details have been reported ( Gorey 
et al., 2010,  2011,  2012,  2013).
RESULTS
Description of Canadian Breast Cancer 
Care Protections
Survival Rates. Comparisons of survival rates be-
tween study cohorts of women in high-poverty 
neighborhoods of California and Ontario are dis-
played at the top of Table 1. First, we compared 
women with NN disease on eight-year survival. 
Overall, these cohorts of women with the most treat-
able type of breast cancer did not differ significantly. 
However, the survival rate among the women in 
Ontario (78.5%) seemed somewhat better than that 
of  women who were uninsured or publicly insured 
in California (70.0%, RR = 1.12). Next, between-
country differences were observed to be much 
greater for NP breast cancer. Overall, five-year 
survival rates were significantly greater in Ontario 
(RR = 1.23) and, as hypothesized, this apparent 
benefit was greater when compared with that for 
women who were uninsured or Medicaid insured 
in California (RR = 1.27). The Californian women 
with NP disease who were uninsured seemed quite 
disadvantaged, as only about half of them survived 
for five years (54.7%), whereas three-quarters of the 
Table 1: Comparisons of the Residents in California and Ontario’s 
Poorest Neighborhoods on Breast Cancer Care and Survival:  
Adjusted Rates and Standardized Rate Ratios
Sample Definition 
Care Characteristic
California Ontario Ontario/California
Sample Rate Sample Rate RR (95% CI)
n % n %
Survival
Node negative (NN) disease
Eight-year survivala 724 76.8 125 78.5 1.02 (0.92, 1.13)
 Private 370 83.2 0.94 (0.85, 1.04)
 Uninsured or public 354 70.0 1.12* (0.99, 1.26)
Node positive (NP) disease
Five-year survival 623 59.9 97 73.7 1.23 (1.05, 1.45)
 Private or Medicare 418 62.5 1.18 (1.00, 1.39)
 Uninsured or Medicaid 205 58.0 1.27 (1.06, 1.53)
 Uninsured 80 54.7 1.35 (1.07, 1.70)
Metastasized disease
Three-year survivalb 129 21.8 8 33.4 1.53 (0.39, 6.02)
 Private or Medicare 78 29.9 1.12 (0.12, 10.33)
 Uninsured or Medicaid 51 13.7 2.44* (0.84, 7.05)
Early Diagnosis
Entire sample
NN disease 1,950 61.5 300 65.0 1.06 (0.96, 1.17)
 Private 805 64.5 1.01 (0.90, 1.13)
 Uninsured or public 1,145 57.9 1.12 (1.01, 1.24)
Surgical Treatment
Entire sample
Had surgeryc 1,947 94.3 300 96.6 1.02* (0.99, 1.05)
 Private or Medicare 1,429 95.0 1.02 (0.98, 1.06)
 Uninsured or Medicaid 518 93.2 1.04 (1.00, 1.08)
NN disease & had surgery
Had BCSd 1,073 49.6 190 73.5 1.48 (1.31, 1.68)
Adjuvant Treatments
Entire sample
Received radiation therapyc 1,950 39.5 300 58.8 1.49 (1.32, 1.69)
 Private 805 42.8 1.37 (1.20, 1.56)
 Uninsured or public 1,145 36.6 1.60 (1.40, 1.82)
(continued )
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women with similarly advanced disease in Ontario 
survived (73.7%, RR = 1.35). We then explored 
three-year survival of women whose disease had 
metastasized, a trend indicative of  better survival in 
Ontario was observed (RR = 1.53), and the survival 
rate in Ontario (33.4%) was much greater than that 
of women who were uninsured or Medicaid insured 
in California (13.7%, RR = 2.44).
Diagnosis and Treatments. Under the subheading 
of early diagnosis in Table 1 it can be seen that over-
all the two cohorts did not differ significantly on 
early diagnosis rates. Moreover, women who were 
privately insured in California (64.5%) had an early 
diagnosis rate essentially identical to that of all On-
tarian women (65.0%, RR = 1.01). However, the 
Ontario rate was significantly better than that of the 
aggregate rate among women who were uninsured 
and Medicaid or Medicare insured in California 
(57.9%, RR = 1.12). The Ontarian women were 
12% more likely to be diagnosed early than were the 
uninsured or publicly insured women in California.
The analyses also strongly suggested that Ontarian 
women with breast cancer living in extreme poverty 
have better access to more effective treatments, 
whether directed toward cure or palliation, especially 
as compared with their inadequately insured Cali-
fornian counterparts. Overall between-country dif-
ferences were minuscule on the receipt of surgery, 
which was received in nearly all instances. However, 
about 4% fewer of the uninsured or Medicaid in-
sured received surgical treatment of their breast can-
cers (RR = 1.04). Of course there are legitimate 
reasons for refusing surgery. It should be noted that 
surgery refusal rates were nearly identical among the 
women in California (10.7%) and Ontario (10.0%) 
who did not have surgery. The between-country 
Table 1: Continued
Sample Definition California Ontario Ontario/California
Care Characteristic Sample Rate Sample Rate RR (95% CI)
 Primary insurers n % n %
NN disease & had BCS
Received radiation therapyd 589 66.4 147 70.6 1.06 (0.98, 1.14)
 Privatee 270 80.8 0.87 (0.77, 0.98)
 Uninsured or public 319 60.6 1.17 (1.01, 1.35)
Hormone receptor positive tumorf
Received hormone therapy 993 41.2 216 68.2 1.65 (1.44, 1.89)
 Private 408 45.7 1.49 (1.29, 1.73)
 Uninsured or public 585 38.3 1.78 (1.53, 2.07)
Wait Times
Had surgery
60+ days wait for surgeryc 1,835 10.4 290 7.2 0.69* (0.45, 1.06)
 Private or Medicare 1,358 9.1 0.79 (0.50, 1.24)
 Uninsured or Medicaid 477 12.4 0.58 (0.36, 0.93)
Non-metastasized disease, no chemotherapy
180+ days wait for RTc 367 5.7 96 6.2 1.09 (0.46, 2.58)
 Private or Medicare 289 2.9 2.14 (0.80, 5.75)
 Uninsured or Medicaid 78 14.2 0.44* (0.18, 1.10)
Optimum Care: BCS < Two Months Postdiagnosis and RT < Four Months Postsurgery
NN & low or intermediate grade
Optimum cared 624 44.5 85 64.0 1.44 (1.16, 1.79)
 Private 244 47.4 1.35* (0.98, 1.86)
 Uninsured or public 345 43.1 1.48 (1.13, 1.94)
 Uninsured 56 33.8 1.89 (1.31, 2.72)
Notes: RR = standardized rate ratio, CI = confidence interval, BCS = breast conserving surgery, RT = radiation therapy. Bolded rate ratios were statistically significant at p < .05. Unless 
noted otherwise, all rates were age-adjusted across these categories: 25 to 44, 45 to 54, 55 to 64, 65 to 74, and 75 or older.
aSamples were restricted to those less than 70 years of age. 
bRates were age-adjusted across these categories: 25 to 64 and 65 or older. 
cRates were age- and stage–adjusted across these categories: 25 to 64 and 65 or older, and NN and NP breast cancer.
dRates were age and tumor size-adjusted across these categories: 25 to 64 and 65 or older, and less than 20 mm and 20 or more mm.
eOnly between-country comparisons indicative of an American advantage.
fEstrogen or progesterone receptor positive.
*p < .10.
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 divide was much greater when a specific surgery was 
considered. Only half of the Californian cohort 
 received BCS (49.6%) compared with three-quarters 
of the Ontarian cohort (73.5%, RR = 1.48), a very 
large, hypothetically consistent Canadian benefit.
Adjuvant treatments are displayed next in Table 1. 
Overall, RT was received by many more in Ontario 
than in California (58.8% versus 39.5%, RR = 1.49), 
and the access gap was even greater among the un-
insured or publicly insured (36.6%, RR = 1.60). 
When RT was most indicated, that is, for women 
with NN disease who received BCS, there was no 
overall difference between the cohorts on RT receipt. 
But the Ontario RT rate (70.6%) was significantly 
better than the aggregate rate among those who 
were uninsured or Medicaid or Medicare insured 
in California (60.6%, RR = 1.17). Alternatively, the 
Ontario RT rate was significantly worse than the 
rate among those who were privately insured in 
California (80.8%, RR = 0.87). The pattern of HT 
findings was similar to that of  RT. HT was received 
by many more in Ontario than in California (68.2% 
versus 41.2%, RR = 1.65), and the gap was even 
greater among the uninsured or publicly insured 
(38.3%, RR = 1.78). No significant between-country 
differences were observed on CT.
Wait Times. Two exemplary wait criteria are dis-
played in Table 1. Overall, the women in Ontario 
seemed less likely to have waited for two months or 
more between their diagnosis and surgery (7.2% 
versus 10.4%, RR = 0.69). As hypothesized, women 
with adequate insurance in California did not differ 
significantly from women in Ontario on such long 
waits for surgery, but those with inadequate insur-
ance in California were substantially more likely to 
experience long waits (12.4%, RR = 0.58). Ontar-
ian women with non-metastasized disease not 
treated with CT were also much less likely to have 
experienced long waits of six months or more for 
RT than were women with inadequate insurance in 
California (6.2% versus 14.2%, RR = 0.44).
Optimum Care. We developed a nominal mea-
sure of optimum treatment of one of the most com-
mon and treatable types of breast cancer—NN and 
low to intermediate grade (localized and “well-
differentiated” tumors that tend to grow and spread 
slowly)—from four study variables: received BCS 
within two months of diagnosis and received adju-
vant RT within four months of surgery. Admittedly, 
it is probably only one of a number of “optimum” 
care criterions with some measure of clinical valid-
ity. About two-thirds of the Ontario cohort received 
such optimum care (64.0%), but less than half of the 
California cohort did (44.5%, RR = 1.44). Hypo-
thetically consistent, the between-country optimum 
care differential was significantly less when Ontarian 
women were compared with women with private 
insurance in California (47.4%, RR = 1.35). The 
differential was much larger when considering the 
uninsured in California (33.8%). The women in 
Ontario were nearly twice as likely to receive opti-
mum care (RR = 1.89).
Canadian Advantages Explained by Health 
Insurance
Three survival analyses are displayed in Table 2: (1) 
long-term, eight-year survival among women less 
than 70 years of age at diagnosis, the majority of 
whom would be expected to survive throughout 
follow-up given life expectancies in the United 
States and Canada, (2) five-year survival among all 
participants, and (3) short-term, three-year survival 
among women with metastasized disease, the major-
ity of whom were probably not treated with the 
intention to cure, but to palliate. In each instance, 
model 1 demonstrated practically significant Cana-
dian survival advantages (respective odds ratios 
[ORs] of 1.56, 1.50, and 2.10) that, as hypothesized, 
were substantially to completely mediated by the 
large and positive effects of having adequate health 
insurance in model 2. Significant main and interact-
ing effects of early diagnosis (model 3) and treatment 
access (model 4) were entered into regression mod-
els in temporal order. Early diagnosis and receipt of 
RT and HT strongly predicted eight-year survival, 
whereas the odds of survival diminished substantially 
for those who waited two months or more for sur-
gery. These diagnostic and treatment effects seemed 
to be the same in both countries, as there was no 
stage or treatment by country interactions. A very 
similar pattern was observed for the prediction of 
five-year survival by early diagnostic, RT, and surgi-
cal wait effects, but in this instance there was also 
one significant interaction effect: early diagnosis by 
country. The advantaging effect of being diagnosed 
with NN disease was significantly larger for the U.S. 
cohort (OR = 4.06, 95% CI 3.26, 5.06) than for the 
Canadian cohort (OR = 1.91, 95% CI 1.07, 3.42). 
We explored possible reasons for this and found that 
when diagnosed later the Canadian women (30.7%) 
were three times as likely as women in the United 
States (9.7%) to be treated very thoroughly with CT, 
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RT, and HT (RR = 3.16, 95% CI 2.19, 4.57). For 
the three-year model, survival odds were five- to 
sixfold greater among women with metastasized 
disease who had received CT or HT in either coun-
try. No significant effects of country remained after 
health insurance, disease stage, and treatments were 
accounted for (respective ORs of 1.09, 1.10, and 
1.00, all nonsignificant).
DISCUSSION
This study compared breast cancer care in high-
poverty neighborhoods in Canada and the United 
States. Using breast cancer as a health care policy 
sentinel we found consistent support for the hypoth-
esis that Canadian women experienced better care 
and outcomes in the years prior to passage of the 
ACA. Such Canadian women were more likely than 
their counterparts in the United States to receive 
BCS, RT, and HT, and those with NP or metasta-
sized disease survived longer. Contrary to prevalent 
rhetoric, Canadian women were less likely to expe-
rience long waits for care. We also found consistent 
support for the hypothesis that Canadian protections 
were even greater when compared with those of U.S. 
women who were uninsured or Medicaid insured. 
Such women in the United States were at greater 
risk of receiving substandard care. They were diag-
nosed later; waited longer for treatment; had much 
less access to BCS, RT, and HT; and were less likely to 
survive. We also observed suggestive Medicare inad-
equacies. Most telling, women in the United States 
who were uninsured or publicly insured by Medic-
aid or Medicare were much less likely than Canadian 
women to receive optimum, evidence-based care. 
Finally, three mathematical models cross-validated 
the hypothesis that health insurance mediated be-
tween-country differences. Better three-, five-, and 
eight-year outcomes among Canadian women were 
primarily explainable by the fact of their more ad-
equate health insurance.
Compared with Canadian women, uninsured 
women in the United States received the most con-
sistently substandard care. Risks of care inadequacies 
were also observed among those who were Medic-
aid insured, and notable detriments were even ob-
served among women in the United States whose 
care was primarily covered by Medicare or by a 
private insurer. These findings seem consistent with 
well-known inequities in U.S. health care. Such ad-
mitted inequities have even come to be reflected in 
Table 2: Associations of Country, Health Insurance, Diagnostic, and Treatment 
Characteristics with Breast Cancer Survival: Logistic Regression Models
Model 1 Model 2 Model 3 Model 4
Characteristic OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Eight-Year Survival among 1,500 Women < 70 Years of Age at Diagnosisa
Country (Canadian advantage) 1.56 (1.12, 2.17) 1.29 (0.91, 1.82) 1.27 (0.89, 1.82) 1.09 (0.75, 1.57)
Medicare or private insurance 1.70 (1.34, 2.15) 1.56 (1.21, 2.00) 1.48 (1.15, 1.91)
NN disease at diagnosis 3.89 (3.09, 4.89) 3.98 (3.15, 5.01)
Waited > 60 days for surgery 0.55 (0.38, 0.78)
Received radiation therapy 1.34 (1.06, 1.70)
Received hormone therapy 1.35 (1.04, 1.75)
Five-Year Survival among all 2,250 Women in the Sampleb
Country (Canadian advantage) 1.50 (1.12, 1.99) 1.31* (0.98, 1.77) 1.33* (0.98, 1.81) 1.10 (0.81, 1.50)
Medicare or private insurance 1.66 (1.31, 2.10) 1.55 (1.21, 1.97) 1.37 (1.07, 1.76)
NN disease at diagnosis 3.65 (2.98, 4.48) 2.90 (2.32, 3.62)
Waited > 60 days for surgery 0.47 (0.35, 0.65)
Received radiation therapy 1.44 (1.17, 1.78)
NN disease at diagnosis by country 0.49 (0.27, 0.90)
Three-Year Survival among 137 Women with Metastasized Disease at Diagnosisc
Country (Canadian advantage) 2.10 (0.47, 9.41) 1.32 (0.27, 6.38) Not applicable 1.00 (0.09, 11.39)
Medicare or private insurance 3.13 (1.11, 8.78) 1.68 (0.41, 6.92)
Received chemotherapy 5.08 (1.00, 26.67)
Received hormone therapy 5.84 (1.54, 22.14)
Notes: OR = odds ratio, CI = confidence interval, NN = node negative. Bolded ORs were statistically significant at p < .05.
aAll effects were age-adjusted across these categories: 25 to 44, 45 to 54, 55 or older. 
bAll effects were age-adjusted across these categories: 25 to 44, 45 to 54, 55 to 64, 65 to 74, 75 or older.
cAll effects were age- and grade-adjusted across these categories: 25 to 64, 65 or older, and low to intermediate or high grade.
*p < .10.
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the language of U.S. health insurance. For example, 
it may go without saying that those covered by 
Medicare need to purchase additional Medigap cov-
erage. Private insurance plans are called “bronze, 
silver, gold, or platinum,” implying that certain 
people have better coverage than others. The prob-
ability of its providing health insurance to tens of 
millions more Americans notwithstanding ( CBO, 
2012), the ACA may not be able to rectify such 
structural inequities. In fact, it has been estimated 
that the vast majority of private plans purchased 
through the ACA’s health insurance exchanges will 
be bronze or silver plans with very high deductibles 
( Wharam, Ross-Degnan, & Rosenthal, 2013). Sim-
ilar structural inequities, including compromised 
coverage with greater out-of-pocket expenses, have 
been predicted for Medicaid’s expansion across 50 
states ( Magge, Cabral, Kazis, & Sommers, 2013). It 
seems possible that many previously uninsured peo-
ple may become underinsured under the ACA, and 
it is people who live in poverty who will be least able 
to absorb the additional, often great, out-of-pocket 
costs of cancer care, for example ( Gorey et al., 2012, 
 2013,  2014). This study suggests that a single-payer 
system of universal health care coverage with global 
budgets and without competition to cover the most 
desirable people for the most profit (or least public 
spending) could avoid such inequities.
Country-level Effect: Universal Access 
versus Inadequate Insurance-based 
Access Gaps
This study’s key country effects, estimated with stan-
dardized RRs or adjusted ORs, ranged from 1.12 
for early diagnosis to 1.50 for the receipt of opti-
mum care and survival. Their direction indicated 
consistent Canadian protective effects, but one 
might wonder about their practical significance in 
population health or policy terms. The attribution 
of risk or protection at the population level is a 
function of three factors of which the effect size 
(RR or OR) is only one. It is also important to 
consider the size of the population at risk and the 
prevalence of exposure to the risk factors being stud-
ied. In this instance, the central exposure or risk 
factor to be mediated is a social one, poverty. The 
other social exposure of interest is the risk of being 
inadequately insured. Nearly a quarter of a million 
women in the United States are diagnosed with 
breast cancer each year, one of every five of whom 
lives in poverty ( American Cancer Society, 2012; 
 Iceland, 2013). This study estimated that six of every 
10 such women are inadequately insured. That rep-
resents an annual population of 30,000 women in 
the United States at risk of receiving less effective 
care than similarly impoverished, but single-payer 
covered, women in Canada.
Extrapolating these statistics and parameters, we 
estimated that 2,100 women living in poverty with 
breast cancer are diagnosed later, 6,300 treated less 
optimally, and 6,900 die earlier each year in the 
United States than would have, had they all enjoyed 
access to a single-payer health care system. That is 
an estimated 31,500 late diagnoses, 94,500 subopti-
mum treatments, and 103,500 premature deaths in 
the United States during this study’s 15-year time 
span. These striking inequities are probably only the 
tip of the population health detriment iceberg, as 
breast cancer accounts for less than 2% of the burden 
of disease in the United States ( Michaud et al., 2006). 
We deem such large population risks attributable to 
inadequate health insurance as evidence not only of 
extraordinary social inequities, but also of profound 
social injustices. The ACA will most assuredly begin 
to close such between-country gaps. However, given 
that substantial populations will probably remain 
uninsured or underinsured in the United States 
( CBO, 2012), substantial care and survival gaps are 
also very likely to remain. This study strongly sug-
gests that single-payer reform of health care in the 
United States would close such gaps even further.
Limitations and Implications
Our analyses demonstrated that poverty and health 
insurance matter, but what of ethnicity? Although 
this study was not able to directly account for this 
factor because the OCR does not code ethnicity, 
we were able to conservatively compare the sub-
sample of non-Hispanic white women in California 
with the entire ethnically diverse sample in Ontario. 
For example, we secondarily analyzed the optimum 
care of women with imminently treatable breast 
cancer, excluding all members of any ethnic minor-
ity group in California. Evidence of significantly 
better access in Canada remained. Furthermore, the 
substantial rate of suboptimum care among women 
of color who were inadequately insured in Califor-
nia did not differ significantly from that of their 
non-Hispanic white counterparts. In short, the dis-
advantaging effects of being uninsured or underin-
sured seem quite similar for all women living in 
poverty in the United States, whether majority white 
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or minority women of color. However, we think that 
ethnic background or racialized group membership 
still very much matters. Women of color comprised 
more than half of this study’s Californian sample. And 
compared with non-Hispanic white women, such 
women of color were 40% more likely to be unin-
sured or Medicaid insured and 20% less likely to have 
private health insurance. So approximately six of 
every 10 of the late diagnoses, suboptimum treat-
ments, and premature deaths in high-poverty California 
neighborhoods were experienced by women of color 
( Galea, Tracy, Hoggatt, DiMaggio, & Karpati, 2011; 
 Steenland & Armstrong, 2006). Even though the risks 
associated with being inadequately insured are similar 
for all women living in poverty in the United States, 
because women of color are more likely to live in 
poverty and to be inadequately insured, they are more 
likely than non-Hispanic white women to experience 
the injustices of contemporary U.S. health care. Race 
still matters ( West, 1993). Other potential limitations 
have been discussed in previous articles ( Gorey et al., 
2010,  2011,  2012,  2013).
Social Work Implications
The risk of living in poverty remains much greater 
among racially or ethnically diverse people in the 
United States. Moreover, this study affirmed again 
that such people experience much greater risks of 
having serious and costly illnesses, of being inad-
equately insured, and so of receiving inadequate 
health care and of dying prematurely. Effective 
Medicaid expansion through the ACA would go a 
long way toward eliminating such oppressive, struc-
tural inequalities in U.S. health care. The uptake of 
ACA changes are likely to be very challenging, 
especially for those who live in poverty or near the 
poverty line, and for racial, ethnic, or cultural mi-
nority people of color ( Gorin, Gehlert, & Washington, 
2010;  Kimbrough-Melton, 2013;  Sommers et al., 
2012). Recent national and statewide surveys con-
sistently found prevalent lack of knowledge about 
ACA changes, especially among those who might 
benefit the most from them ( Barcellos et al., 2014; 
 Blewett, Lukanen, Call, & Dahlen, 2013;  Sinaiko, 
Ross-Degnan, Soumerai, Lieu, &  Galbraith, 2013). 
In aggregate it seems that the majority of those 
living in poverty are presently unprepared to ef-
fectively navigate the post-Obamacare health care 
system. Implications for social work practice are 
clear.  Culturally sensitive social workers, performing 
a continuum of roles, will be needed to ensure that 
people who are presently uninsured gain the best 
possible health insurance, and when needed, enjoy 
the highest-quality health care: outreach, teaching, 
referral, care advocacy, coordination, and follow-up. 
Finally, at the time of this writing, only 28 states and 
the District of Columbia had “opted” to expand 
Medicaid. Surely such an absurd structural inequal-
ity that would disenfranchise millions of Americans 
cannot stand. Social workers in coalition with allied 
professionals and diverse communities ought to ad-
vocate for the full enactment of recent health care 
reforms across all 50 states as we continue to advocate 
for future, single-payer reform of U.S. health care.
CONCLUSION
Women living in poverty with breast cancer receive 
better care and are more likely to survive in Canada 
than in the United States. Prevalent health insurance 
inadequacies in the United States versus universal, 
single-payer coverage in Canada largely explain this 
between-country divide. The ACA will substantially 
reduce such inequities, but additional reforms, in-
cluding the introduction of a single-payer system, 
would further reduce if not completely eliminate 
them. Social justice and policy implications are clear. 
Even as elements of the ACA continue to unfold, 
social workers and allied advocates ought to con-
tinually strive to ensure that all Americans have ac-
cess to the highest-quality health care. 
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